Global Distribution of Businesses Marketing Stem Cell-Based Interventions.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27494673.
- Also identified by DOI 10.1016/j.stem.2016.07.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A structured search reveals that online marketing of stem-cell-based interventions is skewed toward developed economies including the United States, Ireland, Australia, and Germany. Websites made broad, imprecise therapeutic claims and frequently failed to detail procedures. Widespread marketing poses challenges to regulators, bioethicists, and those seeking realistic hope from therapies.
Medical subject headings
- Internationality
- Marketing
- Stem Cells